Hearing and Hearing Loss Progression in Patients with GJB2 Gene Mutations: A Long-Term Follow-Up
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242316763 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Aki Sakata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan. Hauptthemen laut MEDLINE: Deafness, Hearing Loss, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT KAKENHI.
Abstract (Originalsprache)
We aimed to investigate whether the degree of hearing loss with GJB2 mutations could be predicted by distinguishing between truncating and non-truncating mutations and whether the genotype could predict the hearing loss level. Additionally, we examined the progression of hearing loss in individuals monitored for over 2 years for an average of 6.9 years. The proportion of truncating mutations was higher in patients with profound and severe hearing loss, but it was not accurate enough to predict the degree of hearing loss. Via genotype analysis, mutations of the p.Arg143Trp variants were associated with profound hearing loss, while mutations of the p.Leu79Cysfs*3 allele exhibited a wide range of hearing loss, suggesting that specific genotypes can predict the hearing loss level. Notably, there were only three cases of progression in four ears, all of which involved the p.Leu79Cysfs*3 mutation. Over the long-term follow-up, 4000 Hz was significant, and there was a trend of progression at 250 Hz, suggesting that close monitoring at these frequencies during follow-up may be crucial to confirm progression. The progression of hearing loss was observed in moderate or severe hearing loss cases at the time of the initial diagnosis, emphasizing that children with this level of hearing loss need regular follow-ups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology and Head and Neck Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
- Tokyo Teishin Hospital, Tokyo 102-0071, Japan.
ORCID-Profile: Hajime Koyama, Tatsuya Yamasoba
Förderung
- MEXT KAKENHI
Zitieren
APA
Sakata, A., Kashio, A., Koyama, M., Urata, S., Koyama, H., & Yamasoba, T. (2023). Hearing and Hearing Loss Progression in Patients with GJB2 Gene Mutations: A Long-Term Follow-Up. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316763
Vancouver
Sakata A, Kashio A, Koyama M, Urata S, Koyama H, Yamasoba T. Hearing and Hearing Loss Progression in Patients with GJB2 Gene Mutations: A Long-Term Follow-Up. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316763
BibTeX
@article{Sakata2023,
author = {Sakata, Aki and Kashio, Akinori and Koyama, Misaki and Urata, Shinji and Koyama, Hajime and Yamasoba, Tatsuya},
title = {Hearing and Hearing Loss Progression in Patients with GJB2 Gene Mutations: A Long-Term Follow-Up},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242316763}
}
EUVIMED